Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |